Japan stem cell researchers aim at muscular dystrophy

Researchers in Japan said they have been able to stop the deterioration associated with muscular dystrophy by creating stem cells and implanting them in a mouse.

A team of researchers from Asahi Kasei and Kyoto University said it created skeletal muscle stem cells from induced pluripotent stem cells.

The scientists said they planned to attempt the same procedure in a dog before considering human clinical trials. Japan counts about 30,000 people with the disease.

- get the story from Nikkei

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.